Navigation Links
Verum.de Exhibits at Outsourcing in Clinical Trials Southern California
Date:8/29/2013

SAN DIEGO, Aug. 29, 2013 /PRNewswire/ -- Verum.de, a full-clinical service, German-based contract research organization (CRO) with seven offices throughout Europe and a U.S. office in Carlsbad, Calif., will participate in the Outsourcing in Clinical Trials Southern California meeting in San Diego, Sept. 24-25, 2013. Verum will exhibit at booth #3 and will answer questions on conducting international clinical trials, logistics of study medication and bio samples (im- and exportation, packaging, distribution and storage) specifically in Central Eastern European (CEE) countries.

(Logo: http://photos.prnewswire.com/prnh/20120807/LA53176LOGO)  

Southern California is the newest location for the OCT series. This meeting brings together life science professionals interested in growth, innovation and latest trends of the industry, focused on topics relevant to pharma, biotech, and medical device companies. Attendees who visit the Verum booth will have the opportunity to meet Christian Sacher, CEO, Dagmar Siebold, European director of client relations, and US and European business development teams.

"We look forward to expanding our attendance in US industry events and to supporting the life sciences sector in Southern California where one of our offices is located," said Kristi Clark, president of Verum's U.S. office and operations. "With San Diego being one of the major hubs for pharma and biotech in the world, this exhibit will give us the opportunity to showcase our expertise to potential clients and partners interested in clinical trial services in CEE."

To set up an appointment or to learn more about Verum.de, contact Chuck Cade, VP, business development, US at cc@verum.us or call +1 (512) 917-8017.

About Verum.de
Verum has been the first Western-standard full-service CRO specializing in CEE/CIS countries, with key competency in full clinical service for Phases II-IV. Verum has successfully completed more than 130 clinical trials with about 40,000 patients for pharma, biotech and medical device companies as well as the US National Institutes of Health (NIH). The company's expertise covers cardiovascular, neurology, psychiatry, pain, oncology, and more. Operating since 1992, Verum is the strongest player in high recruiting CEE areas and maintains offices all over Eastern Europe, Germany and the US. More information can be found at http://www.verum.de.

CONTACT:
Antonia Genov
antonia@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Verum.de
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Verum.de Chosen to Provide Clinical Research Services for Oncology Center in Romania
2. Verified Clinical Trials Exhibits at the Annual 2013 Partnerships In Clinical Trials to Discuss the Professional Research Subject and the Clinical Trial Database Registry
3. Patheon Exhibits and Presents at the 2013 IQPC Global Formulation and Drug Delivery Summit
4. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
5. NanoLogix Announces Development of Multi-Well, Rapid Diagnostic Test Variant and Exhibits at the American Society for Microbiology General Meeting in San Francisco
6. Clinovo Sponsors Outsourcing in Clinical Trials Southern California Conference 2013, in La Jolla (CA), September 24-25
7. Clinical Development, Contracts and Outsourcing in MENA & APAC, New Webinar Hosted by Xtalks
8. Clinovo Sponsors the First Outsourcing in Clinical Trials: Medical Devices & Diagnostics Conference, June 12-13, 2013 in Saint Paul, Minnesota
9. DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks
10. Cyber Infrastructure Pvt. Ltd. (CIS) Begins Offering BOT (Build-Operate-Transfer) IT-Outsourcing Model for SMEs
11. Global Healthcare Contract Research Outsourcing Market is expected to reach USD 65.03 billion by 2018: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Intelligent Implant ... by the FDA via 510(k) for sale in the United States. These components ... posterior thoraco-lumbar fusions. With one-level sales beginning in October of 2015, the company ...
(Date:4/28/2016)... ... April 28, 2016 , ... Connecticut ... innovative, growing companies, today announced the launch of VentureClash , a $5 ... , “VentureClash looks to attract the best early-stage companies here in ...
(Date:4/27/2016)... ... April 27, 2016 , ... Cambridge Semantics, ... web technology, today announced that it has been named to The Silicon Review’s “20 ... services and other markets, Cambridge Semantics serves the needs of end users facing some ...
(Date:4/27/2016)... 2016 NanoStruck Technologies Inc. ... ( Frankfurt : 8NSK) gibt bekannt, ... 13. August 2015 die Genehmigung von der CNSX ... 200.000.000 Einheiten auf 400.000.000 Einheiten zu erhöhen, um ... wurden 157.900.000 Einheiten mit dem ersten Teil der ...
Breaking Biology Technology:
(Date:3/11/2016)... -- http://www.apimages.com ) - --> http://www.apimages.com ) ... AP Images ( http://www.apimages.com ) - Germany ... the new refugee identity cards. DERMALOG will be unveiling this device, ... Hanover next week.   --> Germany ... produce the new refugee identity cards. DERMALOG will be unveiling this ...
(Date:3/10/2016)... March 10, 2016 --> ... research report "Identity and Access Management Market by Component ... and Governance), by Organization Size, by Deployment, by Vertical, ... by MarketsandMarkets, The market is estimated to grow from ... by 2020, at a Compound Annual Growth Rate (CAGR) ...
(Date:3/9/2016)... March 9, 2016 This BCC Research report ... of the RNA Sequencing (RNA Seq) market for the ... instruments, tools and reagents, data analysis, and services. ... of the RNA-Sequencing market such as RNA-Sequencing tools and ... main factors affecting each segment and forecast their market ...
Breaking Biology News(10 mins):